Faculty, Staff and Student Publications

Publication Date

11-18-2025

Journal

Cell Reports Medicine

DOI

10.1016/j.xcrm.2025.102395

PMID

41187743

PMCID

PMC12711671

PubMedCentral® Posted Date

11-3-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) have garnered significant research attention in the last decade. As key stromal cells of the TME, studies have explored them as a potential target for controlling cancer. Using high-throughput technologies like single-cell RNA sequencing coupled with proteomics, the classification of different CAF subgroups reveals a complex system that varies by cancer type. Unraveling novel big data, potentially through AI platforms, will be key to identifying the role of CAFs in tumor progression and therapy escape mechanisms, enabling new therapies that manipulate CAFs to increase patients' survival. We summarize and discuss new developments in an attempt to target CAFs for cancer control. Furthermore, we explore whether the complex heterogeneity of CAF origins can be targeted by single drugs in the future or require targeted, personalized therapies to combat cancer.

Keywords

Humans, Neoplasms, Cancer-Associated Fibroblasts, Tumor Microenvironment, Animals

Published Open-Access

yes

fx1.jpg (380 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.